BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monto AS. Francis Field Trial of Inactivated Poliomyelitis Vaccine: Background and Lessons for Today. Epidemiologic Reviews 1999;21:7-23. [DOI: 10.1093/oxfordjournals.epirev.a017989] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Horne AD, Lachenbruch PA, Goldenthal KL. Intent-to-treat analysis and preventive vaccine efficacy. Vaccine 2000;19:319-26. [PMID: 10930687 DOI: 10.1016/s0264-410x(00)00152-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. Vaccines. Elsevier; 2008. pp. 605-29. [DOI: 10.1016/b978-1-4160-3611-1.50029-5] [Cited by in Crossref: 15] [Article Influence: 1.2] [Reference Citation Analysis]
3 Songini M, Mannu C, Targhetta C, Bruno G. Type 1 diabetes in Sardinia: facts and hypotheses in the context of worldwide epidemiological data. Acta Diabetol 2017;54:9-17. [DOI: 10.1007/s00592-016-0909-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
4 Goodnow CC. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints. Immunol Cell Biol 2021;99:177-91. [PMID: 33113212 DOI: 10.1111/imcb.12419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
5 Baicus A. History of polio vaccination. World J Virol 2012;1:108-14. [PMID: 24175215 DOI: 10.5501/wjv.v1.i4.108] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
6 D'Amelio E, Salemi S, D'Amelio R. Anti-Infectious Human Vaccination in Historical Perspective. Int Rev Immunol 2016;35:260-90. [PMID: 26606466 DOI: 10.3109/08830185.2015.1082177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Serwer P, Wright ET, Chang JT, Liu X. Enhancing and initiating phage-based therapies. Bacteriophage 2014;4:e961869. [PMID: 26713220 DOI: 10.4161/21597073.2014.961869] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
8 Eisenstein EL. Commentary on Sertkaya et al. and Larson et al. Clinical Trials 2016;13:137-9. [DOI: 10.1177/1740774515626410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Marks HM. The 1954 Salk poliomyelitis vaccine field trial. Clinical Trials 2011;8:224-34. [DOI: 10.1177/1740774511399110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]